Standard stepwise therapy for overactive bladder (OAB) begins with conservative therapies such as lifestyle interventions and behavioral approaches. Medications—anticholinergics or beta-3 agonists—are ...
While potty training is probably a distant childhood memory, the panicked feeling of “I need to pee right now and I don’t know if I can make it to the bathroom in time” is something many adults still ...
Boston Scientific acquires Valencia Technologies' eCoin bladder dysfunction device, expanding into the $30M+ overactive ...
—Maybe, say the results of a UK meta-analysis, which found some patients to benefit from the alternative approach. Considering the side effects of certain OAB medications and poor adherence, it’s ...
Overactive bladder is a long-term condition that won’t go away on its own and may worsen if a person does not get treatment. The condition can be caused by issues in how the brain and bladder ...
CLEVELAND, Ohio (March 1, 2023)—Approximately 33% of American women will experience overactive bladder syndrome (OAB), which interferes with daily activities, social functioning, and sleep quality.
After two-plus years of quarantines and travel restrictions, it’s no surprise many of us are making up for lost time, booking trips and scheduling long-overdue visits with friends and loved ones.
New analyses of data from the Phase 3 EMPOWUR Extension Study of GEMTESA® (vibegron) 75 mg provided additional insight into the long-term effects of the product. These data were featured in podium ...
Boston Scientific (NYSE:BSX) announced today that it entered into an agreement to acquire Valencia Technologies for an ...
Monroe-based medical technology company Elidah has a new product, the Elitone Urge, designed to help provide relief for overactive bladder in women. The new device, a successor to the Elitone, is an ...
SAN FRANCISCO - It may not kill you, but living with an overactive bladder can be a significant drain on your sleep and productivity, not to mention your general quality of life. An estimated 33 ...